2023

A preclinical randomized controlled multi-centre trial of anti-interleukin-17A treatment for acute ischaemic stroke
Gelderblom M, Koch S, Strecker J, Jørgensen C, Garcia-Bonilla L, Ludewig P, Schädlich I, Piepke M, Degenhardt K, Bernreuther C, Pinnschmidt H, Arumugam T, Thomalla G, Faber C, Sedlacik J, Gerloff C, Minnerup J, Clausen B, Anrather J, Magnus T
BRAIN COMMUN. 2023;5(2):fcad090.

2021

Interleukin-10 improves stroke outcome by controlling the detrimental Interleukin-17A response
Piepke M, Clausen B, Ludewig P, Vienhues J, Bedke T, Javidi E, Rissiek B, Jank L, Brockmann L, Sandrock I, Degenhardt K, Jander A, Roth V, Schädlich I, Prinz I, Flavell R, Kobayashi Y, Renné T, Gerloff C, Huber S, Magnus T, Gelderblom M
J NEUROINFLAMM. 2021;18(1):.

2020

Medin aggregation causes cerebrovascular dysfunction in aging wild-type mice
Degenhardt K, Wagner J, Skodras A, Candlish M, Koppelmann A, Wild K, Maxwell R, Rotermund C, von Zweydorf F, Gloeckner C, Davies H, Madine J, Del Turco D, Feederle R, Lashley T, Deller T, Kahle P, Hefendehl J, Jucker M, Neher J
P NATL ACAD SCI USA. 2020;117(38):23925-23931.

2018

Innate immune memory in the brain shapes neurological disease hallmarks
Wendeln A, Degenhardt K, Kaurani L, Gertig M, Ulas T, Jain G, Wagner J, Häsler L, Wild K, Skodras A, Blank T, Staszewski O, Datta M, Centeno T, Capece V, Islam M, Kerimoglu C, Staufenbiel M, Schultze J, Beyer M, Prinz M, Jucker M, Fischer A, Neher J
NATURE. 2018;556(7701):332-338.

2015

Replacement of brain-resident myeloid cells does not alter cerebral amyloid-β deposition in mouse models of Alzheimer's disease
Varvel N, Grathwohl S, Degenhardt K, Resch C, Bosch A, Jucker M, Neher J
J EXP MED. 2015;212(11):1803-9.

Persistence of Aβ seeds in APP null mouse brain
Ye L, Fritschi S, Schelle J, Obermüller U, Degenhardt K, Kaeser S, Eisele Y, Walker L, Baumann F, Staufenbiel M, Jucker M
NAT NEUROSCI. 2015;18(11):1559-61.

Letzte Aktualisierung aus dem FIS: 20.11.2024 - 23:32 Uhr